{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:49:06Z","timestamp":1773708546639,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12325-019-01113-2","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T19:02:56Z","timestamp":1570820576000},"page":"3299-3307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Leber\u2019s Hereditary Optic Neuropathy as a Promising Disease for Gene Therapy Development"],"prefix":"10.1007","volume":"36","author":[{"given":"Cuneyt","family":"Karaarslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"issue":"2","key":"1113_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01694557","volume":"17","author":"T Leber","year":"1871","unstructured":"Leber T. Ueber hereditaere und congenital angelegte sehnervenleiden. Graefes Arch Clin Exp Ophthalmol. 1871;17(2):249\u201391.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1113_CR2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"PY Man","year":"2003","unstructured":"Man PY, Griffiths PG, Brown DT. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72(2):333\u20139.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1113_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","volume":"46","author":"P Yu-Wai-Man","year":"2009","unstructured":"Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46(3):145\u201358.","journal-title":"J Med Genet"},{"issue":"10","key":"1113_CR4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejhg.5201828","volume":"15","author":"A Puomila","year":"2007","unstructured":"Puomila A, Hamalainen P, Kivioja S, Savontaus ML, Koivumaki S, Huoponen K. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007;15(10):1079\u201389.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1113_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55(4):299\u2013334.","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"1113_CR6","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1074\/jbc.M210285200","volume":"278","author":"A Ghelli","year":"2003","unstructured":"Ghelli A, Zanna C, Porcelli AM, Schapira AH, Martinuzzi A, Carelli V. Leber\u2019s hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J Biol Chem. 2003;278(6):4145\u201350.","journal-title":"J Biol Chem"},{"issue":"4","key":"1113_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ajmg.a.20456","volume":"124A","author":"A Gropman","year":"2004","unstructured":"Gropman A, Chen TJ, Perng CL, Krasnewich D, Chernoff E, Tifft C. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A. 2004;124A(4):377\u201382.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1113_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","volume":"63","author":"JA Fraser","year":"2008","unstructured":"Fraser JA, Ross-Cisneros CPF. Pathoimmunologic findings which are important in the etiology of mitochondrial DNA disease in adults. Ann Neurol. 2008;63(1):35\u20139.","journal-title":"Ann Neurol"},{"issue":"6","key":"1113_CR9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archneur.64.6.890","volume":"64","author":"L Spruijt","year":"2007","unstructured":"Spruijt L, Smeets HJ, Hendrickx A, Bettink-Remeijer MW, Maat-Kievit A, Schoonderwoerd KC. A MELAS-associated ND1 mutation causing Leber hereditary optic neuropathy and spastic dystonia. Arch Neurol. 2007;64(6):890\u20133.","journal-title":"Arch Neurol"},{"issue":"1","key":"1113_CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53\u201389.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"1113_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ana.20236","volume":"56","author":"ML Valentino","year":"2004","unstructured":"Valentino ML, Barboni P, Ghelli A, Bucchi L, Rengo C, Achilli A. The ND1 gene of complex I is a mutational hot spot for Leber\u2019s hereditary optic neuropathy. Ann Neurol. 2004;56(5):631\u201341.","journal-title":"Ann Neurol"},{"issue":"Pt 8","key":"1113_CR12","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/brain\/awq155","volume":"133","author":"C La Morgia","year":"2010","unstructured":"La Morgia C, Ross-Cisneros FN, Sadun AA, et al. Melanopsin retinal ganglion cells are resistant to neurodegenerationin mitochondrial optic neuropathies. Brain. 2010;133(Pt 8):2426\u201338.","journal-title":"Brain"},{"issue":"12","key":"1113_CR13","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/jnnp.2003.024372","volume":"75","author":"C Battisti","year":"2004","unstructured":"Battisti C, Formichi P, Cardaioli E, Bianchi S, Mangiavacchi P, Tripodi SA. Cell response to oxidative stress induced apoptosis in patients with Leber\u2019s hereditary optic neuropathy. J Neurol Neurosurg Psychiatry. 2004;75(12):1731\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1113_CR14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/147323000803600320","volume":"36","author":"JY Wang","year":"2008","unstructured":"Wang JY, Gu YS, Wang J, Tong Y. Oxidative stress in Chinese patients with Leber\u2019s hereditary optic neuropathy. J Int Med Res. 2008;36(3):544\u201350.","journal-title":"J Int Med Res"},{"issue":"9","key":"1113_CR15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000267843.10977.4a","volume":"69","author":"R McFarland","year":"2007","unstructured":"McFarland R, Chinnery PF, Blakely EL, et al. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology. 2007;69(9):911\u20136.","journal-title":"Neurology"},{"issue":"2","key":"1113_CR16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bjo.2003.027664","volume":"88","author":"MJ Barron","year":"2004","unstructured":"Barron MJ, Griffiths P, Turnbull DM, Bates D, Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol. 2004;88(2):286\u201390.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1113_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1755-3768.1985.tb01526.x","volume":"63","author":"T Seedorff","year":"1985","unstructured":"Seedorff T. The inheritance of Leber\u2019s disease. A genealogical follow-up study. Acta Ophthalmol. 1985;63(2):135\u201345.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1113_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/519394","volume":"81","author":"G Hudson","year":"2007","unstructured":"Hudson G, Carelli V, Spruijt L, et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA\u2013haplogroup background. Am J Hum Genet. 2007;81(2):228\u201333.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"1113_CR19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archopht.1993.01090110057023","volume":"111","author":"DR Johns","year":"1993","unstructured":"Johns DR, Smith KH, Miller NR, Sulewski ME, Bias WB. Identical twins who are discordant for Leber\u2019s hereditary optic neuropathy. Arch Ophthalmol. 1993;111(11):1491\u20134.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1113_CR20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.49.4.1136","volume":"49","author":"V Biousse","year":"1997","unstructured":"Biousse V, Browne MD, Newman NJ, et al. De novo 14484 mitochondrial DNA mutation in monozygotic twins discordant for Leber\u2019s hereditary optic neuropathy. Neurology. 1997;49(4):1136\u20138.","journal-title":"Neurology"},{"issue":"Pt 9","key":"1113_CR21","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A. Gene environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132(Pt 9):2317\u201326.","journal-title":"Brain"},{"issue":"Pt 5","key":"1113_CR22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/119.5.1481","volume":"119","author":"RM Chalmers","year":"1996","unstructured":"Chalmers RM, Harding AE. A case-control study of Leber\u2019s hereditary optic neuropathy. Brain. 1996;119(Pt 5):1481\u20136.","journal-title":"Brain"},{"issue":"5","key":"1113_CR23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bjo.83.5.577","volume":"83","author":"K Tsao","year":"1999","unstructured":"Tsao K, Aitken PA, Johns DR. Smoking as an aetiological factor in a pedigree with Leber\u2019s hereditary optic neuropathy. Br J Ophthalmol. 1999;83(5):577\u201381.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1113_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13816810701867607","volume":"29","author":"SP Shankar","year":"2008","unstructured":"Shankar SP, Fingert JH, Carelli V, et al. Evidence for a novel X-linked modifier locus for Leber hereditary optic neuropathy. Ophthalmic Genet. 2008;29(1):17\u201324.","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"1113_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies\u2013disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81\u2013114.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"1113_CR26","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","volume":"6","author":"RH Haefeli","year":"2011","unstructured":"Haefeli RH, Erb M, Gemperli AC. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One. 2011;6(3):e17963.","journal-title":"PLoS One"},{"issue":"9","key":"1113_CR27","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"K Klopstock","year":"2011","unstructured":"Klopstock K, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134(9):2677\u201386.","journal-title":"Brain"},{"issue":"12","key":"1113_CR28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbadis.2009.03.002","volume":"1792","author":"LM Cree","year":"2009","unstructured":"Cree LM, Samuels DC, Chinnery PF. The inheritance of pathogenic mitochondrial DNA mutations. Biochim Biophys Acta. 2009;1792(12):1097\u2013102.","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 1","key":"1113_CR29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awq276","volume":"134","author":"C Giordano","year":"2011","unstructured":"Giordano C, Montopoli M, Perli E. Oestrogens ameliorate mitochondrial dysfunction in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134(Pt 1):220\u201334.","journal-title":"Brain"},{"issue":"2","key":"1113_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.125.2.268","volume":"125","author":"XP Qi","year":"2007","unstructured":"Qi XP, Sun L, Hauswirth WW. Use of mitochondria antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol. 2007;125(2):268\u201372.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1113_CR31","doi-asserted-by":"crossref","first-page":"E2316","DOI":"10.3390\/molecules23092316","volume":"23","author":"Y Jang","year":"2018","unstructured":"Jang Y, Lim K. Recent advances in mitochondria-targeted gene delivery. Molecules. 2018;23(9):E2316.","journal-title":"Molecules"},{"issue":"12","key":"1113_CR32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/adhm.201300037","volume":"2","author":"XC Ma","year":"2013","unstructured":"Ma XC, Wang XB, Zhou M, Fei HA. Mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing. Adv Healthc Mater. 2013;2(12):1638\u201343.","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"1113_CR33","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1021\/nl801908y","volume":"8","author":"SV Boddapati","year":"2008","unstructured":"Boddapati SV, D\u2019Souza GG, Erdogan S, Torchilin VP, Weissig V. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett. 2008;8(8):2559\u201363.","journal-title":"Nano Lett"},{"issue":"1","key":"1113_CR34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3866\/PKU.WHXB20110120","volume":"27","author":"WX Wang","year":"2011","unstructured":"Wang WX, He YF, Shang YZ, Liu HL. Interaction between the gemini surfactant (12-6-12) and DNA. Acta Physico-Chim Sin. 2011;27(1):156\u201362.","journal-title":"Acta Physico-Chim Sin"},{"issue":"1","key":"1113_CR35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbamem.2010.09.026","volume":"1808","author":"AM Cardoso","year":"2011","unstructured":"Cardoso AM, Faneca H, Almeida JA, et al. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency. Biochim Biophys Acta. 2011;1808(1):341\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"1113_CR36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.colsurfa.2014.12.013","volume":"480","author":"R Salvado","year":"2015","unstructured":"Salvado R, Sousa F, Queiroz J, Costa D. Development of mitochondrial targeting plasmid DNA nanoparticles: characterization and in vitro studies. Colloid Surf A. 2015;480:287\u201395.","journal-title":"Colloid Surf A"},{"issue":"6","key":"1113_CR37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/bc015508l","volume":"12","author":"S Futaki","year":"2001","unstructured":"Futaki S, Ohashi W, Suzuki T, et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem. 2001;12(6):1005\u201311.","journal-title":"Bioconjug Chem"},{"issue":"1\u20132","key":"1113_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(03)00297-9","volume":"92","author":"GGM D\u2019Souza","year":"2003","unstructured":"D\u2019Souza GGM, Rammohan R, Cheng SM, Torchilin VP, Weissig V. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J Control Release. 2003;92(1\u20132):189\u201397.","journal-title":"J Control Release"},{"key":"1113_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mito.2017.06.005","volume":"37","author":"Y Bae","year":"2017","unstructured":"Bae Y, Jung MK, Song SJ, et al. Functional nanosome for enhanced mitochondria-targeted gene delivery and expression. Mitochondrion. 2017;37:27\u201340.","journal-title":"Mitochondrion"},{"key":"1113_CR40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.05.016","volume":"136","author":"Y Yamada","year":"2017","unstructured":"Yamada Y, Ishikawa T, Harashima H. Validation of the use of an artificial mitochondrial reporter DNA vector containing a cytomegalovirus promoter for mitochondrial transgene expression. Biomaterials. 2017;136:56\u201366.","journal-title":"Biomaterials"},{"issue":"3","key":"1113_CR41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2012.01.009","volume":"159","author":"S Biswas","year":"2012","unstructured":"Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release. 2012;159(3):393\u2013402.","journal-title":"J Control Release"},{"issue":"3","key":"1113_CR42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1021\/mp9002877","volume":"7","author":"JL Santos","year":"2010","unstructured":"Santos JL, Pandita D, Rodrigues J, et al. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells. Mol Pharm. 2010;7(3):763\u201374.","journal-title":"Mol Pharm"},{"issue":"2","key":"1113_CR43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1476-5381.2009.00288.x","volume":"157","author":"P Midoux","year":"2009","unstructured":"Midoux P, Pichon C, Yaouanc JJ, Jaffres PA. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol. 2009;157(2):166\u201378.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"1113_CR44","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/acs.biomac.6b01056","volume":"17","author":"JA Chuah","year":"2016","unstructured":"Chuah JA, Matsugami A, Hayashi F, Numata K. Self-assembled peptide-based system for mitochondrial-targeted gene delivery: functional and structural insights. Biomacromolecules. 2016;17(11):3547\u201357.","journal-title":"Biomacromolecules"},{"issue":"4","key":"1113_CR45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","volume":"21","author":"S Daya","year":"2008","unstructured":"Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev. 2008;21(4):583\u201393.","journal-title":"Clin Microbiol Rev"},{"issue":"20","key":"1113_CR46","doi-asserted-by":"crossref","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","volume":"109","author":"H Yu","year":"2012","unstructured":"Yu H, Koilkonda RD, Chou TH, et al. Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber\u2019s hereditary optic neuropathy in a mouse model. Proc Natl Acad Sci USA. 2012;109(20):E1238\u201347.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1113_CR47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaophthalmol.2013.7630","volume":"132","author":"RD Koilkonda","year":"2014","unstructured":"Koilkonda RD, Yu H, Chou TH, et al. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Ophthalmol. 2014;132(4):409\u201320.","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"1113_CR48","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1167\/iovs.14-15388","volume":"55","author":"R Koilkonda","year":"2014","unstructured":"Koilkonda R, Yu H, Talla V, et al. LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile. Invest Ophthalmol Vis Sci. 2014;55(12):7739\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1113_CR49","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/mtm.2015.3","volume":"2","author":"H Cwerman-Thibault","year":"2015","unstructured":"Cwerman-Thibault H, Augustin S, Lechauve C, et al. Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss. Mol Ther Methods Clin Dev. 2015;2:15003.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"1113_CR50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","volume":"123","author":"WJ Feuer","year":"2016","unstructured":"Feuer WJ, Schiffman JC, Davis JL, et al. Gene therapy for Leber hereditary optic neuropathy: initial results. Ophthalmology. 2016;123(3):558\u201370.","journal-title":"Ophthalmology"},{"key":"1113_CR51","doi-asserted-by":"crossref","first-page":"21587","DOI":"10.1038\/srep21587","volume":"6","author":"X Wan","year":"2016","unstructured":"Wan X, Pei H, Zhao MJ, et al. Efficacy and safety of rAAV2-ND4 treatment for Leber\u2019s hereditary optic neuropathy. Sci Rep. 2016;6:21587.","journal-title":"Sci Rep"},{"key":"1113_CR52","first-page":"258","volume":"10","author":"S Yang","year":"2016","unstructured":"Yang S, Ma SQ, Wan X, et al. Long-term outcomes of gene therapy for the treatment of Leber\u2019s hereditary optic neuropathy. EBio Med. 2016;10:258\u201368.","journal-title":"EBio Med"},{"key":"1113_CR53","unstructured":"Vignal C, Uretsky S, Thomasson N, et al. Recombinant AAV2 containing the wild type ND4 gene (RAVV2\/2-ND4) is an experimental gene therapy for vision loss in LHON due to the ND4 mitochondrial mutation: phase I\/IIa safety investigation results and upcoming pivotal phase III efficacy studies. In: North-American Neuro-Ophthalmology Society 42nd annual meeting, February 27\u2013March 3, 2016; Tucson, Arizona."},{"issue":"6","key":"1113_CR54","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ophtha.2017.12.036","volume":"125","author":"S Vignal","year":"2018","unstructured":"Vignal S, Uretsky S, Fitoussi S, et al. Safety of rAVV2\/2-ND4 gene therapy for Leber\u2019s hereditary optic neuropathy. Ophthalmology. 2018;125(6):945\u20137.","journal-title":"Ophthalmology"},{"key":"1113_CR55","unstructured":"Thomasson N, Cwerman-Thibault H, Augustin S, et al. Safety, local tolerability and biodistribution of GS010 (AAV2\/2-ND4), a gene therapy medicinal product in development for Leber\u2019s hereditary optic neuropathy (LHON). ARVO Annual Meeting, 2014. Invest Ophthalmol Vis Sci. 2014;55:3340."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01113-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T23:36:58Z","timestamp":1602286618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01113-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}